ROYAL BANK OF CANADA - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 2 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$136,000
+615.8%
17,069
+700.2%
0.00%
Q2 2023$19,000
+46.2%
2,133
-52.2%
0.00%
Q1 2023$13,000
-65.8%
4,460
-59.5%
0.00%
Q4 2022$38,000
-29.6%
11,015
+63.6%
0.00%
Q3 2022$54,000
+5.9%
6,732
+2.8%
0.00%
Q2 2022$51,000
-47.4%
6,551
-17.4%
0.00%
Q1 2022$97,000
+31.1%
7,934
+31.9%
0.00%
Q4 2021$74,000
+94.7%
6,016
+64.1%
0.00%
Q3 2021$38,000
+90.0%
3,666
+67.0%
0.00%
Q2 2021$20,000
+122.2%
2,195
+173.0%
0.00%
Q1 2021$9,000
+28.6%
804
-24.9%
0.00%
Q4 2020$7,0001,0710.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders